drugset / Trial / NCT04415346
A Single Center, Phase I Clinical Trial to Evaluate the Safety of LIZTOX Inj in the Treatment of Post Stroke Upper Limb Spasticity
NaSingle-groupOpen-labelTreatment
Summary
* Investigational Product: LIZTOX inj 100unit(HU-014) * Title : A Single Center, Phase I Clinical Trial to Evaluate the Safety of LIZTOX Inj in the Treatment of Post Stroke Upper Limb Spasticity * Sites and investigators : Asan Medical Center(Seoul), Min-ho Chun, M.D, Ph.D * Objective : To evaluate the safety of LIZTOX inj in the treatment of Post Stroke Upper Limb Spasticity
Timeline
- Start
- 2019-11-06
- Primary completion
- 2020-06
- Completion
- 2020-10
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | HU-014 | Unknown | 360 iu | Intramuscular |